BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11720743)

  • 61. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
    Kang YH; Kim KS; Yu YK; Lim SC; Kim YC; Park KO
    J Korean Med Sci; 2001 Aug; 16(4):417-23. PubMed ID: 11511786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis].
    Delmotte P; Martin B; Paesmans M; Berghmans T; Mascaux C; Meert AP; Steels E; Verdebout JM; Lafitte JJ; Sculier JP
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):577-84. PubMed ID: 12473944
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer.
    Inoshima N; Nakanishi Y; Minami T; Izumi M; Takayama K; Yoshino I; Hara N
    Clin Cancer Res; 2002 Nov; 8(11):3480-6. PubMed ID: 12429638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
    Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
    Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
    Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
    Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma.
    Saito H; Tsujitani S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Surgery; 1999 Feb; 125(2):195-201. PubMed ID: 10026754
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunohistochemical study on VEGF expression in endometrial carcinoma--comparison with p53 expression, angiogenesis, and tumor histologic grade.
    Fujisawa T; Watanabe J; Akaboshi M; Ohno E; Kuramoto H
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):668-74. PubMed ID: 11710596
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis.
    Seto S; Onodera H; Kaido T; Yoshikawa A; Ishigami S; Arii S; Imamura M
    Cancer; 2000 Jan; 88(2):295-301. PubMed ID: 10640960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression.
    Faviana P; Boldrini L; Spisni R; Berti P; Galleri D; Biondi R; Camacci T; Materazzi G; Pingitore R; Miccoli P; Fontanini G
    Oncol Rep; 2002; 9(3):617-20. PubMed ID: 11956638
    [TBL] [Abstract][Full Text] [Related]  

  • 74. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma.
    Linderholm B; Lindh B; Tavelin B; Grankvist K; Henriksson R
    Int J Cancer; 2000 Jan; 89(1):51-62. PubMed ID: 10719731
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship of p53 and vascular endothelial growth factor expression of clinicopathological factors in human scirrhous gastric cancer.
    Baba M; Konno H; Maruo Y; Tanaka T; Kanai T; Matsumoto K; Matsuura M; Nishino N; Maruyama K; Nakamura S; Baba S
    Eur Surg Res; 1998; 30(2):130-7. PubMed ID: 9565747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.
    Kieser A; Weich HA; Brandner G; Marmé D; Kolch W
    Oncogene; 1994 Mar; 9(3):963-9. PubMed ID: 8108142
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vascular endothelial growth factor and p53 expressions in liver and abdominal metastases from colon cancer.
    Cascinu S; Graziano F; Catalano V; Barni S; Giordani P; Baldelli AM; Staccioli MP; Rossi C; Brenna A; Valenti A; Muretto P; Catalano G
    Tumour Biol; 2003; 24(2):77-81. PubMed ID: 12853702
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.
    Fontanini G; Boldrini L; Chinè S; Pisaturo F; Basolo F; Calcinai A; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Br J Cancer; 1999 Jan; 79(2):363-9. PubMed ID: 9888482
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer.
    Ishigami SI; Arii S; Furutani M; Niwano M; Harada T; Mizumoto M; Mori A; Onodera H; Imamura M
    Br J Cancer; 1998 Nov; 78(10):1379-84. PubMed ID: 9823983
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.